WiseGuyReports.Com Publish a New Market Research Report On –“ Hypercalcemia Treatment Industry – Treatment, Outlook, Analysis, Research, Review to 2025”.
Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast cancer, and myeloma.
The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.
The growing preference for combination therapy is estimated to drive the growth prospects for the global hypercalcemia treatment market until the end of 2023. The adoption rate and preference for hypercalcemia drugs is increasing in developed countries with the growing use of hypercalcemia drugs in combination with other therapies. For instance, researchers have evaluated the use of combination drugs, which includes pamidronate and calcitonin. Additionally, it has also been observed that the reduction in elevated serum parathyroid hormone (PTH) levels and the improvement of bone mineral density can be achieved using denosumab (DMAb) and calcitriol. Such combination therapies will lead to a new therapeutic strategy to reverse severe bone loss due to therapy-resistant SHPT in individuals with CKD.
For more information or any query mail at firstname.lastname@example.org
In 2018, the global Hypercalcemia Treatment market size was 8590 million US$ and it is expected to reach 19100 million US$ by the end of 2025, with a CAGR of 10.5% during 2019-2025.
This report focuses on the global Hypercalcemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypercalcemia Treatment development in United States, Europe and China.
The key players covered in this study
Market segment by Type, the product can be split into
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Hypercalcemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hypercalcemia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Table Of Contents – Major Key Points
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hypercalcemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.4 Calcimimetic Agents
1.5 Market by Application
1.5.1 Global Hypercalcemia Treatment Market Share by Application (2014-2025)
1.5.2 Mild Hypercalcemia
1.5.3 Moderate Hypercalcemia
1.5.4 Severe Hypercalcemia
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hypercalcemia Treatment Market Size
2.2 Hypercalcemia Treatment Growth Trends by Regions
2.2.1 Hypercalcemia Treatment Market Size by Regions (2014-2025)
2.2.2 Hypercalcemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hypercalcemia Treatment Market Size by Manufacturers
3.1.1 Global Hypercalcemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Hypercalcemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hypercalcemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hypercalcemia Treatment Key Players Head office and Area Served
3.3 Key Players Hypercalcemia Treatment Product/Solution/Service
3.4 Date of Enter into Hypercalcemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
12 International Players Profiles
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hypercalcemia Treatment Introduction
12.1.4 AbbVie Revenue in Hypercalcemia Treatment Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hypercalcemia Treatment Introduction
12.2.4 Amgen Revenue in Hypercalcemia Treatment Business (2014-2019)
12.2.5 Amgen Recent Development
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hypercalcemia Treatment Introduction
12.3.4 Merck Revenue in Hypercalcemia Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hypercalcemia Treatment Introduction
12.4.4 Novartis Revenue in Hypercalcemia Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 OPKO Health
12.5.1 OPKO Health Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hypercalcemia Treatment Introduction
12.5.4 OPKO Health Revenue in Hypercalcemia Treatment Business (2014-2019)
12.5.5 OPKO Health Recent Development
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.